Sexual symptoms often untreated during breast cancer endocrine therapy
Sexual dysfunction, genital and urinary symptoms were common among people receiving endocrine therapy for breast cancer, a review found.
Sexual dysfunction, genital and urinary symptoms were common among people receiving endocrine therapy for breast cancer, a review found.
The authors reviewed evolving evidence on how timing during pregnancy influences treatment decisions and outcomes for both mother and baby.
The U.S. FDA approved vepdegestrant (Veppanu) for adults with ER-positive, HER2-negative breast cancer and mutations in the ESR1 gene.
Early-life abuse and neglect may influence long-term pain and daily functioning in women with breast cancer, researchers found.
Structured, supervised exercise during chemotherapy can provide consistent benefits for breast cancer patients.
A recent study of breast cancer survivors treated with endocrine therapy found acupuncture may improve sleep quality and reduce hot flashes.
Sexual distress remained stable after breast cancer treatment and was linked to demoralization and self-compassion.
Black women with a common type of breast cancer are more likely to have aggressive tumors than white women.
Both chemical cooling caps and automated scalp cooling systems are safe and can help prevent chemotherapy-induced hair loss, a study found.
Complications after breast-conserving surgery were linked to a 6.45-fold higher risk of delayed adjuvant therapy, a study found.